LRRK2 and Parkinson disease: Given the observation of dopamine transmission deficits in several LRRK2 mutant rodent models [21], [39], [40], [41], the potential connection of PKA-LRRK2 signaling indicates an attractive cellular pathway for the future dissection of the molecular mechanism underlying LRRK2 mutations in the pathogenesis of PD.